A new study examines the potential impact of the Medicare Prescription Payment Plan (M3P)—an opt-in policy implemented in 2025 under the Inflation Reduction Act that allows beneficiaries to spread out-of-pocket (OOP) costs over the calendar year—on Medicare Part D beneficiaries with cancer who face high out-of-pocket (OOP) prescription drug costs.
This article was originally published on MedicalXpress.com
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
By Daniel Zane Bryant, author of “Living with Food Allergies: A Complete Lifestyle Guide” (available on Amazon at https://www.amazon.com/dp/B0G2BcGB2K) Navigating food allergies might initially feel overwhelming, yet it presents an exciting opportunity to reimagine familiar […]
© 2025 SimplyWell.ca